Lipid Status After Pancreas-Kidney Transplantation

Objective –This study was performed to determine the net effects of euglycemia, resolution of renal failure, immunosuppressant drugs, and hyperinsulinemia on fasting lipid profiles of patients with renal failure and insulin-dependent diabetes mellitus (IDDM) after combined pancreas-kidney transplantation (PKT). Research Design and Methods –Thirty subjects with IDDM received PKT between April 1989 and October 1990, and all were studied. Mean ± SE age was 35.2 ± 1.3 yr; 19 recipients were men, and 11 were women. All had a functioning pancreatic allograft post-PKT. Fasting lipid profiles including total cholesterol (C), triglyceride (TG), high-density lipoprotein cholesterol (HDL-chol), and C/HDL-chol were compared before and after PKT (38–555 days divided into groups: preoperation and 0–2, 3–8, and 9–19 mo). Results –Significant hyperlipidemia was observed preoperatively (means ± SE): C, 5.92 ± 0.27 mM; HDL-chol, 1.07 ± 0.09 mM; TG, 5.85 ± 0.56 mM; and C/HDL-chol, 6.49 ± 0.83. All lipids and C/HDL-chol dropped immediately after PKT (0-2 mo vs. preoperation, all P < 0.01, except HDL-chol). After this immediate postoperative period, C, HDL-chol, and TG stabilized at new concentrations. C (5.44 ± 0.22 mM) and TG (4.54 ± 0.48 mM) levels were < preoperation (not statistically significant and P < 0.05, respectively). HDL-chol was greater than preoperative values (1.29 ± 0.06 mM, P < 0.05). C/HDL-chol dropped after PKT (0-2 mo, 4.85 ± 0.18, P < 0.01) and continued to decrease throughout the observation period (3-8 mo, 4.42 ± 0.23; 9-19 mo, 4.23 ± 0.23; both P < 0.01 vs. preoperation). There was no statistical difference between lipid concentrations in male and female subjects. Conclusions –The lipid status of subjects with IDDM and renal failure was abnormal before PKT and once lipid concentrations stabilized after PKT (> 2 mo), HDL-chol was higher and TG and C/HDL-chol levels were significantly lower than preoperative values. If these changes are sustained, risk of future cardiovascular disease in this group of patients might be significantly reduced.

[1]  J. Mann,et al.  The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy. , 1990, Transplantation.

[2]  K. Osei,et al.  Physiological and Pharmacological Stimulation of Pancreatic Islet Hormone Secretion in Type I Diabetic Pancreas Allograft Recipients , 1990, Diabetes.

[3]  D. Hricik,et al.  Combined kidney and pancreas transplantation. A safe and effective treatment for diabetic nephropathy. , 1990, Archives of surgery.

[4]  R. Loewenson,et al.  Influence of Pancreas Transplantation on Cardiorespiratory Reflexes, Nerve Conduction, and Mortality in Diabetes Mellitus , 1990, Diabetes.

[5]  P. Diem,et al.  Systemic Venous Drainage of Pancreas Allografts as Independent Cause of Hyperinsulinemia in Type I Diabetic Recipients , 1990, Diabetes.

[6]  S. Grundy.  Management of hyperlipidemia of kidney disease. , 1990, Kidney international.

[7]  A. Sheil,et al.  Coronary artery disease is the major late complication of successful cadaveric renal transplantation , 1990 .

[8]  P. Garvin,et al.  Evolution of synchronous renal and pancreatic transplantation. , 1989, American journal of surgery.

[9]  R. Stratta,et al.  Combined liver and pancreas procurement with Belzer-UW solution. , 1989, Surgery.

[10]  C. Berne,et al.  A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. , 1989, The New England journal of medicine.

[11]  R. Ramsay,et al.  A 10‐Year Experience with 290 Pancreas Transplants at a Single Institution , 1989, Annals of surgery.

[12]  C. V. van Buren,et al.  LIPID ABNORMALITIES IN CYCLOSPORINE‐PREDNISONE‐TREATED RENAL TRANSPLANT RECIPIENTS , 1989, Transplantation.

[13]  E. Bonora,et al.  Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. , 1989, The New England journal of medicine.

[14]  R. Corry,et al.  Comparison of fasting serum cholesterol levels between diabetic recipients who undergo renal-pancreas transplants and renal transplantation only. , 1989, Transplantation proceedings.

[15]  A. Kampik,et al.  Fate of Late Complications in Type I Diabetic Patients After Successful Pancreas-Kidney Transplantation , 1989, Diabetes.

[16]  R. Stratta,et al.  Experience with Simultaneous Pancreas‐kidney Transplantation , 1988, Annals of surgery.

[17]  R. Ramsay,et al.  Pancreas transplantation in nonuremic, type I diabetic recipients. , 1988, Surgery.

[18]  P. Goldwasser,et al.  Lipids in diabetic and nondiabetic hemodialysis and CAPD patients. , 1988, ASAIO transactions.

[19]  B. Kasiske.  Risk factors for accelerated atherosclerosis in renal transplant recipients. , 1988, The American journal of medicine.

[20]  C. Lardinois,et al.  The effects of antihypertensive agents on serum lipids and lipoproteins. , 1988, Archives of internal medicine.

[21]  R. Rubin,et al.  Combined kidney and pancreas transplantation in diabetics. , 1988, Archives of surgery.

[22]  J. Huttunen,et al.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.

[23]  R. Merion,et al.  Pancreatic transplantation--University of Michigan. , 1987, Transplantation proceedings.

[24]  M. Lopes-Virella,et al.  Pharmacological treatment of lipid disorders in diabetes mellitus. , 1987, Diabetes/metabolism reviews.

[25]  J. Chapman,et al.  Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression. , 1987, Transplantation proceedings.

[26]  R. Corry,et al.  Surgical treatment of diabetic nephropathy with simultaneous pancreatic duodenal and renal transplantation. , 1986, Surgery, gynecology & obstetrics.

[27]  L. Carlson,et al.  Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. , 2009, Acta medica Scandinavica.

[28]  A. Gelet,et al.  Metabolic control of type I (insulin dependent) diabetes after pancreas transplantation. , 1985, British medical journal.

[29]  G. Reaven,et al.  Effects of noninsulin-dependent diabetes mellitus on the uptake of very low density lipoproteins by thioglycolate-elicited mouse peritoneal macrophages. , 1985, The Journal of clinical endocrinology and metabolism.

[30]  B Buis,et al.  Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial. , 1985, The New England journal of medicine.

[31]  H. Lithell,et al.  Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10-year follow-up of Uppsala primary preventive study. , 1985, Atherosclerosis.

[32]  D. Hunninghake,et al.  Effects of thiazide diuretics on plasma lipids and lipo-proteins in mildly hypertensive patients: a , 2020 .

[33]  G. Reaven,et al.  Diabetic Hypertriglyceridemia: Evidence for Three Clinical Syndromes , 1981, Diabetes.

[34]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[35]  G Bucolo,et al.  Quantitative determination of serum triglycerides by the use of enzymes. , 1973, Clinical chemistry.

[36]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[37]  R. Morfin,et al.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. , 1970, Journal of lipid research.